AbbVie Inc. (ABBV)
@ABBV.asset
$198.47
At close:
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
Figures
- Sector Healthcare
- Industry Drug Manufacturers
- Index S&P 500
- Market Cap $350.37 B
- Last Earnings Report Feb 14, 2025
- Price Reaction to Earnings Report -2.03%
- Enterprise Value $412.00 B
- Dividend Yield 0.03%
- P/E ratio 82.07
- Price/Sales ratio 6.23
- EV/Sales ratio 7.31
- Price/Book Value 104.37
- Revenue $56.33 B
- EBIT $8.63 B
- Net Income $4.28 B
- Gross Profit $39.43 B
- Free Cash Flow $17.83 B
- EBIT Margin 15.32%
- Gross Margin 69.99%
- FCF Margin 31.65%
- Return on Equity 127.17%
- Equity Ratio 2.49%
- Debt/Equity Ratio 39.18
- 6-month Performance -0.65%
- 12-month Performance 27.94%
- Trend reversal neutral
What the community is saying
| Nobody said anything, yet! Speak your mind and be the first to create a new topic. |